Bradykinin RB2/BDKRB2 Antibody (471916) [mFluor Violet 610 SE]

• Reactivity: Hu
• Applications: Flow, IHC, CyTOF-ready
• Clone: 471916
• Clonality: Monoclonal
• Host: Mouse
• Conjugate: mFluor Violet 610 SE

Bradykinin RB2/BDKRB2 Antibody (471916) [mFluor Violet 610 SE] Summary

• Immunogen: NS0 mouse myeloma cell line transfected with human Bradykinin RB2/BDKRB2
  Met1-Gln391
  Accession # P30411
• Specificity: Detects human Bradykinin RB2/BDKRB2 in direct ELISAs.
• Isotype: IgG2b
• Clonality: Monoclonal
• Host: Mouse

Applications/Dilutions

• Dilutions:
  • CyTOF-ready
  • Flow Cytometry
  • Immunohistochemistry
• Application Notes: Optimal dilution of this antibody should be experimentally determined.

Packaging, Storage & Formulations

• Storage: Store at 4C in the dark.
• Buffer: 50mM Sodium Borate
• Preservative: 0.05% Sodium Azide

Notes

mFluor(TM) is a trademark of AAT Bioquest, Inc. This conjugate is made on demand. Actual recovery may vary from the stated volume of this product. The volume will be greater than or equal to the unit size stated on the datasheet.

Alternate Names for Bradykinin RB2/BDKRB2 Antibody (471916) [mFluor Violet 610 SE]

• B2 bradykinin receptor
• B2R
• BDKRB2
• BK-2 receptor
• BK2
• BK-2
• BKR2
• Bradykinin RB2
• bradykinin receptor B2
• BradykininRB2
• BRB2
• DKFZp686O088

Background

BDKRB2, or Bradykinin Receptor B2, mediates smooth muscle contraction, induces relaxation of arteries, and stimulates diuresis. In addition, bradykinin B2 receptor has been implicated in inflammation and response to pain. This receptor is encoded by a single-copy gene. Two variants are produced by alternate start codons. BDKRB2/Bradykinin B2 receptor expression has been reported in blood, brain, eye, kidney, liver, lung, prostate, skin, small intestine, synovium, uterus, and vessel. ESTs have been isolated from colon, connective tissue, heart, heart/melanocyte/uterus, kidney, lung, placenta, and thyroid libraries.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.